ClinicalTrials.gg
Sign In

Coronary Artery Disease clinical trials

The registry lists 4,861 studies for Coronary Artery Disease across more than 10 countries. 892 are recruiting or about to start. 3,801 of them are mainly about Coronary Artery Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 12,218 studies for Coronary Artery Disease. How that becomes 4,856 here

This page counts the studies the registry files under Coronary Artery Disease, and those it files under no condition that list Coronary Artery Diseasethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 12,218Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −101List Coronary Artery Disease as a condition, but the registry did not file them under itMost often written as “Multivessel Coronary Artery Disease” (16), “Microvascular Coronary Artery Disease” (13), and “Multi Vessel Coronary Artery Disease” (12). The registry filed them under other conditions only, most often ST Elevation Myocardial Infarction (16) and Angina Pectoris (15).
  3. −7,261Match it another way345 name it in the title, 22 in a keyword, and 6,894 by a synonym or other text the search reads.
  4. 4,856The count on this page113 of them list Coronary Artery Disease in their own words; the registry filed them under no condition.

Get an email when these change. Save the Coronary Artery Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
2,556
Status unknown
778
Recruiting
588
Terminated
272
Not yet recruiting
265
Active, not recruiting
225

Phase

Phase 4
656
Phase 3
324
Phase 2
310
Phase 1
124
Early Phase 1
18

Where

United States
1,105
China
542
Germany
365
Korea, Republic of
361
Italy
302
United Kingdom
283

Who runs them

Abbott Medical Devices (79) · Yonsei University (64) · Seung-Jung Park (59) · China National Center for Cardiovascular Diseases (57) · National Heart, Lung, and Blood Institute (NHLBI) (48) · Boston Scientific Corporation (46) · Seoul National University Hospital (44) · Cordis Corporation (41)

What is being tested here

Drugs under test in Coronary Artery Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin7652
Colchicine6523
Ticagrelor51874
Prasugrel4840
PCSK9 Inhibitor404
Clopidogrel3871
Rivaroxaban3314
Empagliflozin308
Dapagliflozin307
Semaglutide325

Drug classes tested here P2Y12 inhibitors 10 open · NSAIDs 8 open · SGLT2 inhibitors 6 open · GLP-1 receptor agonists 4 open · Statins 3 open

Coming up

34phase 3 studies under way
267studies finish main data collection within a year8 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 588 Coronary Artery Disease studies recruiting now, 403 (69%) set no upper age limit and 68 (12%) stop at 75 or younger. 38 (6%) take children under 18. 7 (1%) are for women only and 7 (1%) for men only; 47 (8%) take healthy volunteers.

Recruiting studies that take each age, of 588
AgeWomenMen
1031 (5%)31 (5%)
18446 (76%)443 (75%)
30526 (89%)524 (89%)
40549 (93%)549 (93%)
50565 (96%)566 (96%)
65569 (97%)570 (97%)
75545 (93%)544 (93%)
85465 (79%)463 (79%)

Across all 4,861 studies, recruiting or not: 14% stop at 75 or younger and 4% at 65; 7% take children; 1% are for women only and 2% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronary Artery Disease studies take

Of 193 phase 4 interventional studies under Coronary Artery Disease, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 17 mo4–27 · 34 studies——
Phase 228 mo16–39 · 55 studies15 mo9–29 · 26 studies—
Phase 347 mo20–58 · 61 studies49 mo24–55 · 29 studies—
Phase 435 mo19–58 · 193 studies—36 mo21–59 · 180 studies
Interventional, no phase30 mo15–50 · 930 studies24 mo14–40 · 177 studies33 mo15–53 · 753 studies
Observational41 mo21–87 · 760 studies27 mo15–40 · 125 studies48 mo23–122 · 635 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting11

Show 6 more

Results posted1

Stopped2

Newly registered28

Show 23 more

Studies

Recruiting first, then most recently updated. Showing 50 of 4,861. Browse all 4,861 → or search them.